Abstract:
Objective To explore the predictive value of insulin-like growth factor-1 (IGF-1) level for ventricular remodeling in elderly patients with acute myocardial infarction complicated by heart failure after sacubitril/valsartan treatment.
Methods A total of 120 elderly patients with acute myocardial infarction complicated by heart failure admitted to Longnan First People's Hospital from May 2021 to May 2024 were enrolled as subjects. All patients received percutaneous coronary intervention (PCI) followed by sacubitril/ valsartan treatment after procedure. According to the median level of IGF-1 (118.6 ng·mL
-1) after 4 weeks of treatment, the patients were divided into low-level group (
n = 65) and high-level group (
n = 55), and the general data of the two groups were compared. Logistic regression models were constructed, with covariates gradually included for stratified adjustment from model 1 to model 4. The variance inflation factor (VIF) was used to detect and eliminate collinear variables, so as to analyze the independent correlation between IGF-1 level and the risk of ventricular remodeling in elderly patients with acute myocardial infarction complicated by heart failure. In addition, the patients were divided into left ventricular remodeling group (ΔLVEDVI > 20%,
n = 67) and left ventricular non-remodeling group (ΔLVEDVI ≤ 20%,
n = 53) according to the percentage change in left ventricular end-diastolic volume index (ΔLVEDVI). The general data of the two groups were compared, and a mediation model was established to analyze the mediating roles of nitric oxide (NO), endothelial nitric oxide synthase (eNOS), interleukin-6 (IL-6) between IGF-1 and left ventricular remodeling.
Results There were statistically significant differences in PCI procedure time, fasting blood glucose, glycated hemoglobin (HbA1c), C-reactive protein (CRP), NO, eNOS, IL-6, left ventricular mass index (LVMI), end-diastolic interventricular septal thickness (IVST) and end-diastolic left ventricular posterior wall thickness (LVPWT) among patients with different IGF-1 levels (
P < 0.05). After stepwise adjustment of covariates by Logistic regression and elimination of collinear variables by VIF screening, IGF-1 still showed an independent correlation with the risk of ventricular remodeling. The mediation model analysis showed that NO, eNOS and IL-6 all exerted partial mediating effects between IGF-1 and left ventricular remodeling (
P < 0.001).
Conclusion In elderly patients with acute myocardial infarction complicated by heart failure after PCI, serum IGF-1 level is independently and negatively correlated with the risk of ventricular remodeling after 4 weeks of sacubitril/valsartan treatment. The lower the IGF-1 level, the higher the risk of ventricular remodeling. Posttreatment IGF-1 can be used as a potential biomarker to assess the risk of ventricular remodeling in elderly patients with heart failure, providing new insights for elucidating the mechanism of ventricular remodeling and the prevention and treatment of heart failure.